Related Funds
Fund Name | Location |
Abstract | California, San Francisco, United States |
ADATA Technology | Taipei, Taiwan |
AdMaster | China, Shanghai |
Center of Aging and Brain Health Innovation | Canada, Ontario, Toronto |
CincoVentures | California, San Francisco, United States |
Cypher Holdings | - |
CYTS Hongqi Partnership | - |
DZ BANK | Frankfurt, Germany, Hessen |
Horizon Holding Group | - |
K2 | Bellevue, United States, Washington |
National Institute of General Medical Science | Bethesda, Maryland, United States |
NEO Investment Partners | England, London, United Kingdom |
Nooky Box | - |
Qingdao Jinshi Haorui Investment | China, Qingdao, Shandong |
Sopra Steria | France, Ile-de-France, Paris |
Two Sigma Private Investments | - |
TZP Group | New York, New York, United States |
Yamato Shinkin | Japan, Nara Prefecture, Sakurai |
Zencap | Berlin, Berlin, Germany |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Restore Vision | $5M | 15 Dec 2023 | Chiyoda, Japan | ||
Viage Therapeutics | $10M | 06 Jan 2022 | San Francisco, California, United States | ||
Kyoto Fusioneering | $1M | 12 Oct 2020 | Uji, Kyoto Prefecture, Japan | ||
$455K | 03 Sep 2020 | Kyoto, Kyoto Prefecture, Japan | |||
Rege Nephro | $3M | 04 Jun 2020 | Kyoto, Kyoto Prefecture, Japan | ||
Fimecs | $5M | 28 May 2020 | Japan, Kanagawa Prefecture | ||
LegalForce Japan | $9M | 28 Feb 2020 | Chiyoda, Japan | ||
Kyoto Fusioneering | $685K | 31 Jan 2020 | Japan, Kyoto Prefecture | ||
Myoridge | $837K | 17 Jan 2020 | Japan, Kyoto Prefecture |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Restore Vision | $5M | 15 Dec 2023 | Chiyoda, Japan | ||
Viage Therapeutics | $10M | 06 Jan 2022 | San Francisco, California, United States | ||
Kyoto Fusioneering | $1M | 12 Oct 2020 | Uji, Kyoto Prefecture, Japan | ||
$455K | 03 Sep 2020 | Kyoto, Kyoto Prefecture, Japan | |||
Rege Nephro | $3M | 04 Jun 2020 | Kyoto, Kyoto Prefecture, Japan | ||
Fimecs | $5M | 28 May 2020 | Japan, Kanagawa Prefecture | ||
LegalForce Japan | $9M | 28 Feb 2020 | Chiyoda, Japan | ||
Kyoto Fusioneering | $685K | 31 Jan 2020 | Japan, Kyoto Prefecture | ||
Myoridge | $837K | 17 Jan 2020 | Japan, Kyoto Prefecture |